Press Room

Press Room

BPI: Planning, patient, and payer problems hurting gene therapy rollouts

Dr. Adnan Jaigirdar joins Dark Horse Consulting Group as Head of Clinical

Dr. Kim Benton on FDA's Draft Platform Guidance for CGT

Amanda Mack and Alicja Fiedorowicz on FDA's Draft Guidance on Safety Testing of Human Allogeneic Cells

Blake Bergam and Sara Mills on FDA's Guidance on Human- and Animal-Derived Materials in CGT

"The sweet cell of success," by DHC's Blackford and Manley

Parts 1 & 2 of DHC's Morse and Fiedorowicz on "Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Tx"

Via Insights Bio: "Challenges and benefits in harnessing platform processes for viral vector manufacture"

Dr. Kristin Baird joins Dark Horse Consulting as Master Practice Expert